1. Home
  2. CNTN vs SWKH Comparison

CNTN vs SWKH Comparison

Compare CNTN & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$3.58

Market Cap

185.3M

Sector

Health Care

ML Signal

N/A

Logo SWK Holdings Corporation

SWKH

SWK Holdings Corporation

HOLD

Current Price

$16.70

Market Cap

198.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNTN
SWKH
Founded
2017
1996
Country
United States
United States
Employees
12
9
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Financial Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
185.3M
198.4M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
CNTN
SWKH
Price
$3.58
$16.70
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
441.5K
104.8K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$9.18
Revenue Growth
N/A
N/A
52 Week Low
$2.89
$13.86
52 Week High
$5.27
$17.90

Technical Indicators

Market Signals
Indicator
CNTN
SWKH
Relative Strength Index (RSI) 55.74 32.19
Support Level $3.01 $14.69
Resistance Level $3.82 $17.08
Average True Range (ATR) 0.24 0.37
MACD 0.04 -0.05
Stochastic Oscillator 69.47 12.06

Price Performance

Historical Comparison
CNTN
SWKH

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

About SWKH SWK Holdings Corporation

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

Share on Social Networks: